StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) income statement

EVHNYSEServices-Management ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$3.93−0.69 (-14.94%)

Close on Nov 18, 2026Market cap $444.32MP/E –Yield –

Evolent Health, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
17.2%
Operating margin
-20.4%
Net margin
-24.1%
Return on equity, FY2025
-75.5%

Financial strength

Current ratio
1.24
Debt to equity
2.52
Debt to assets
49.0%
Cash to current liabilities
23.5%

Valuation

P/E ratio
–
Price to sales
0.21
Price to book
1.16
Dividend yield
–

See a number that looks wrong?